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IN VIVO MEASUREMENT OF TRANSLATIONAL AND 
ROTATIONAL LAXITY OF RABBIT KNEES 
AD Heine[, MJ Rudert, TO McKinley, DC Fredericks, JA Bobst, Y 
Tochigi 
Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA 
Aim of Study: The aim of this study was to design and evaluate 
a device to measure rabbit knee joint laxity as a function of partial 
and full ACL sectioning, as a way to explore the pathomechanics 
of osteoarthritis. 
Methods: The testing device for measuring rabbit knee joint lax- 
ity consists of a main cradle with an integral femur clamp, a 
free-floating tibia clamp, and interchangeable linear stepper mo- 
tor/load cell modules - one for translational and one for rotational 
testing (Fig. 1). The rotational test module incorporates a rack- 
and-pinion linkage to convert linear to rotary motion. Both mod- 
ules include a method to adjust knee flexion angle to 90 or 135 
degrees. Test control and data acquisition are by user-written 
LabView programs running on a laptop computer. 
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Fig. 1. Rabbit knee testing system, translational (left) and rotational (right) 
modules. 
To prepare a rabbit for testing, coronal plane transverse pins are 
inserted through the rabbit leg, two in the tibia and one in the 
distal femur. The pins are accurately placed using a drill guide, 
and serve to reproducibly position the leg in the test device for 
repeated testing. During testing, the rabbit is on its back and the 
femur is held fixed vertically. The translational module draws the 
tibia upward for a specified distance and speed, then returns to 
the home position. The rotational module rotates the tibia in one 
direction and then the other, then returns to the home position; 
test angles and speed are user-specified. Force-displacement or 
torque-angle data are displayed and saved to a file. 
We evaluated the effects of preconditioning, intra-operator e- 
peatability (by removing and replacing the rabbit in the fixture), 
knee flexion angle, and ACL sectioning. 
Results: Three to four preconditioning cycles were sufficient to 
get repeatable cycle-to-cycle results. Removing and replacing the 
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Fig. 2. Rabbit knee stiffness with drawer test, intact vs. sectioned and 90 vs. 
135 degrees knee flexion. 
Table 1. Repeatability ofrabbit knee stiffness when rabbit is removed from 
the fixture and replaced (n=3) 
Knee angle Drawer test Rotation test 
90 ° 5.2% 6.9% 
135 ° 1.6% 4.4% 
rabbit from the fixture had little effect on the testing results (Table 
1). The testing device can measure the difference in stiffness of 
a rabbit knee when the knee is at 90 vs. 135 degrees, and when 
the ACL is intact vs. sectioned (Fig. 2). 
Conclusions: This device can be used to determine rabbit knee 
laxity in vivo. 
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QUANTIFICATION OF AGGRECAN FRAGMENTS IN 
SYNOVIAL FLUID IN HUMAN OSTEOARTHRITIS 
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LS Lohmander 1 
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Aim of study: Quantification of aggrecanase generated 
374ARGS and matrix metalloproteinase (MMP) generated 
342 FFGV neoepitope aggrecan fragments in human osteoarthritis 
(OA) synovial fluid. 
Introduction: Although most current reports suggest that a ma- 
jority of the destructive aggrecanolysis in human OA is due to ag- 
grecanase activity in the interglobular domain (IG D), other studies 
suggest that variable but quantitatively not well determined pro- 
portions of the IGD cleavage may be due to activity of MMP's. A 
quantitative and specific assay to monitor degradation of aggre- 
can is an important ool in the development of disease modifying 
therapies in OA, but has proven challenging to develop. We have 
in Western immunoblots quantified the aggrecanase generated 
374ARGS and MMP generated 342FFGV neoepitope fragments in 
a pool of human OA synovial fluid. 
Methods: Human synovial fluid aggrecan was purified from 
pooled synovial fluids from 47 OA patients by dissociative CsCI 
centrifugation, collecting the D1 fraction; proteinase inhibitors be- 
ing present in all steps. As quantification standards, aggrecan 
(A1D1 fraction) from adult human articular cartilage was com- 
pletely converted to either 374ARGS or 342FFGV fragments (with 
corresponding G1-TEGE 373 and GI-IPEN 341 fragments) by di- 
gestion with MMP-3 or with ADAMTS-4. The standards were as- 
sumed to contain one nmol 342FFGV or 374ARGS fragments per 
mg aggrecan dry weight, using a molecular weight of 1 xl  06 g/mol 
aggrecan. Prior to SDS-PAGE and immunoblotting all samples 
were deglycosylated with chondroitinase ABC, keratanase and 
keratanase II. Aggrecan neoepitope antibodies recognizing the 
374ARGS and 342FFGV neoepitope sequences were used. The 
detection and quantification was conducted in a luminescence 
image analyzer (Fujifilm LAS-1000) using Image Gauge version 
4.0 (Fujifilm) software. Samples and standards were used within 
a linear range of the imaging system. 
Results: The content in pooled synovial fluid of large size aggre- 
can fragments with N-terminals374ARGS and 342FFGV was 107 
and 40 pmoles per ml, respectively, out of a total concentration 
of aggrecan fragments of about 185 pmoles per ml. The resulting 
mol/mol ratio of 374ARGS over 342FFGV was 2.7 in this pool of 
human OA synovial fluids. 
Conclusions: We have in Western immunoblots, using neoepi- 
tope antibodies, quantified aggrecanase generated 374ARGS and 
MMP generated 342FFGV neoepitope aggrecan fragments in a 
pool of human OA synovial fluid. Monitoring the relative contents 
of these fragments in individual patient samples over time might 
